Table 5 Prognostic factors for MPeM stratified according to treatment (χ2 test)
From: Analysis of prognostic factors of patients with malignant peritoneal mesothelioma
Variable | Treatment | P value | ||
|---|---|---|---|---|
Cisplatin | Cisplatin + pemetrexed | Non-treatment | ||
Age (years) | ||||
< 63 | 21 | 10 | 6 | |
≥ 63 | 15 | 4 | 15 | P < 0.05 |
Gender | ||||
Male | 10 | 5 | 10 | |
Female | 25 | 9 | 11 | P > 0.05 |
BMI | ||||
< 22.79 | 15 | 7 | 13 | |
≥ 22.79 | 20 | 7 | 8 | P > 0.05 |
Asbestos exposure | ||||
Yes | 28 | 13 | 16 | |
No | 7 | 1 | 5 | P > 0.05 |
Histological subtype | ||||
Epithelial | 23 | 10 | 17 | |
Biphasic + sarcomatoid | 12 | 4 | 4 | P > 0.05 |